Price alert —
Sign in to get a one-time email the moment GCTK crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · GCTK
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-12-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-09-30 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-06-30 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare GCTK vs peers
Line GCTK up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with GCTK
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| GCTK ★ | $0B | 0.1 | — | — | -0.2 | -1.5 | — | — | — | -313.95% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 2.55%
| Holder | Shares | % out |
|---|---|---|
| Geode Capital Management, LLC | 47,001 | 0.75% |
| Ikarian Capital, LLC | 45,830 | 0.73% |
| HRT Financial LP | 40,631 | 0.65% |
| Boothbay Fund Management, LLC | 13,525 | 0.22% |
| Vanguard Fiduciary Trust Co | 4,722 | 0.08% |
| Alerus Financial NA | 4,000 | 0.06% |
| Tower Research Capital LLC (TRC) | 3,442 | 0.05% |
| UBS Group AG | 702 | 0.01% |
| SBI Securities Co., Ltd. | 9 | — |
| NFSG Corp | 34 | — |
Insider activity · 90d
No insider trades for GCTK in last 90d.
Analyst estimates
yfinanceWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
Consensus: none (mean None). Distribution requires FINNHUB_API_KEY.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| DEF 14A | 2026-07-17 | DEF 14A | view · |
| 8-K | 2026-07-15 | 8-K | view · |
| 8-K | 2026-05-15 | 8-K | view · |
| 10-Q | 2026-05-14 | 10-Q | view · |
| 8-K | 2026-05-14 | 8-K | view · |
| 8-K | 2026-05-07 | 8-K | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| 8-K | 2026-04-14 | 8-K | view · |
| 10-K | 2026-03-30 | 10-K | view · |
| 8-K | 2026-03-30 | 8-K | view · |
| 8-K | 2026-03-27 | 8-K | view · |
| 8-K | 2026-03-13 | 8-K | view · |
| DEF 14A | 2026-02-09 | DEF 14A | view · |
| 8-K | 2026-01-29 | 8-K | view · |
| 8-K | 2025-12-31 | 8-K | view · |
| 8-K | 2025-12-29 | 8-K | view · |
| 8-K | 2025-11-13 | 8-K | view · |
| 10-Q | 2025-11-13 | 10-Q | view · |
| 8-K | 2025-11-07 | 8-K | view · |
| 8-K | 2025-11-06 | 8-K | view · |
| 8-K | 2025-11-03 | 8-K | view · |
| 8-K | 2025-10-29 | 8-K | view · |
| 8-K | 2025-10-28 | 8-K | view · |
| 4 | 2025-10-07 | PRIMARY DOCUMENT | view · |
| 4 | 2025-10-07 | PRIMARY DOCUMENT | view · |
| 4 | 2025-10-07 | PRIMARY DOCUMENT | view · |
| 4 | 2025-10-07 | PRIMARY DOCUMENT | view · |
| DEF 14A | 2025-10-03 | DEF 14A | view · |
| S-1 | 2025-09-29 | S-1 | view · |
| 8-K | 2025-09-12 | 8-K | view · |
| 8-K | 2025-09-11 | 8-K | view · |
| 10-Q | 2025-08-14 | 10-Q | view · |
| 8-K | 2025-08-14 | 8-K | view · |
| 8-K | 2025-08-06 | 8-K | view · |
| 8-K | 2025-07-31 | 8-K | view · |
| 8-K | 2025-07-24 | 8-K | view · |
| 8-K | 2025-07-08 | 8-K | view · |
| 8-K | 2025-06-25 | 8-K | view · |
| 8-K | 2025-06-16 | 8-K | view · |
| 8-K | 2025-06-12 | 8-K | view · |
| 8-K | 2025-06-04 | 8-K | view · |
| 8-K | 2025-05-23 | 8-K | view · |
| 8-K | 2025-05-20 | 8-K | view · |
| 10-Q | 2025-05-14 | 10-Q | view · |
| 8-K | 2025-05-14 | 8-K | view · |
| 8-K | 2025-05-13 | 8-K | view · |
| 8-K | 2025-04-29 | 8-K | view · |
| DEF 14A | 2025-04-28 | Proxy statement | view · |
| 8-K | 2025-04-16 | Material event (8-K) | view · |
| 8-K | 2025-04-04 | Material event (8-K) | view · |
| 8-K | 2025-04-03 | Material event (8-K) | view · |
| 10-K | 2025-03-31 | Annual report (10-K) | view · |
| 8-K | 2025-03-31 | Material event (8-K) | view · |
| 4 | 2025-03-31 | PRIMARY DOCUMENT | view · |
| 4 | 2025-03-31 | PRIMARY DOCUMENT | view · |
| 4 | 2025-03-31 | PRIMARY DOCUMENT | view · |
| 4 | 2025-03-31 | PRIMARY DOCUMENT | view · |
| 4 | 2025-03-28 | PRIMARY DOCUMENT | view · |
| 4 | 2025-03-28 | PRIMARY DOCUMENT | view · |
About GCTK
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Options picks · GCTK
ITM + OTM ideas from the latest scanLoading…
Congress trades · GCTK
STOCK Act disclosuresLoading…
SEC filings & insiders · GCTK
EDGAR · liveLoading…
Holders · GCTK
Institutions & insider activityLoading…